Selection of medicines in Chilean public hospitals: an exploratory study

被引:4
|
作者
Collao, Juan F. [1 ,2 ]
Smith, Felicity [2 ]
Barber, Nick [2 ]
机构
[1] Univ Valparaiso, Fac Farm, Dept Ciencias Farmaceut, Valparaiso 2360102, Chile
[2] UCL Sch Pharm, Dept Practice & Policy, London WC1H 9JP, England
关键词
FORMULARY DECISION-MAKING; RATIONAL PHARMACOTHERAPY; THERAPEUTICS COMMITTEES; DRUG; ADOPTION; PHARMACY; DETERMINANTS; DIFFUSION;
D O I
10.1186/1472-6963-13-10
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: There is a growing interest in high income countries to control expenditure on medicines by improving the rationale for their selection. However, in middle income countries with differing priorities and needs, little attention has been paid to this issue. In this paper we explore the policies and processes for the selection and use of medicines in a group of hospitals in Chile, a middle income country which has recently joined the OECD. Methods: A combination of qualitative and quantitative methods was used. A national survey questionnaire was distributed to investigate the role and operation of PTCs ( Pharmacy and Therapeutics Committees). Interviews were conducted with key actors in the selection of medicines in large urban public hospitals. Results: The national survey had an overall response rate of 42% ( 83 out of 196), whilst 7 out of 14 hospitals participated in the qualitative study. High complexity hospitals are large urban hospitals; all of which claim to have a working PTC. The pharmacy offices are mainly involved in dispensing medicines with little involvement in clinical duties. The interviews conducted suggest that the formulary of all the hospitals visited is no more than a stock list. PTCs are unable to influence the prescribing practices of doctors. Members do not feel prepared to challenge the opinions of specialists requesting a certain drug, and decisions are based primarily on costs. The inclusion of medicines in the clinical practice of hospitals is as a result of doctors bypassing the PTC and requesting the purchase of exceptional items, some of which are included in the formulary if they are widely used. Conclusions: There is an urgent need to develop medicine policies in hospitals in Chile. The procedures used to purchase medicines need to be revised. Central guidance for PTCs could help ensure a more rational use of medicines. PTCs need to be empowered to design formularies which cover all the clinical needs of doctors, training members in the analysis of scientific evidence beyond their own specialities. An influential PTC can take the appropriate measures and design workable policies to enforce a cost effective-use of resources.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Selection of medicines in Chilean public hospitals: an exploratory study
    Juan F Collao
    Felicity Smith
    Nick Barber
    BMC Health Services Research, 13
  • [2] Characterization of celiac disease in chilean public hospitals
    Mendez, Constanza
    Carrasco, Mario
    Mora, Betty
    Araya, Magdalena
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2018, 89 (06):
  • [3] Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan
    Alabbadi, Ibrahim
    Almomani, Emad
    Alshazili, Muna
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 21 : 211 - 221
  • [4] Technical and scale efficiency of public community hospitals in Eritrea: An exploratory study
    Kirigia J.M.
    Asbu E.Z.
    Health Economics Review, 3 (1) : 1 - 16
  • [5] Adequacy of nutritionist (dietician) resources in Chilean public hospitals
    Crovetto M., Mirta
    REVISTA MEDICA DE CHILE, 2015, 143 (11) : 1468 - 1477
  • [6] Latvia - New regulation for selection of medicines in Latvian hospitals
    Pirsko, Valdis
    EJHP PRACTICE, 2008, 14 (02): : 13 - 13
  • [7] Evaluation and selection of new medicines in Spanish hospitals in 2006
    Ortega, A.
    Puigventos, F.
    Duran, E.
    Santos, B.
    Requena, T.
    GACETA SANITARIA, 2009, 23 : 14 - 14
  • [8] Access to anticancer medicines in public hospitals of Northwestern China
    Ma, Yue
    Peng, Jin
    Yao, Xuelin
    Feng, Liuxin
    Shi, Xinke
    Jiang, Minghuan
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [9] Hybrid medicines in France. Hybrid medicines: Overviews in France and in Paris Public Hospitals
    Leclerc, E.
    Fusier, I
    Paubel, P.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2021, 79 (06): : 664 - 689
  • [10] Essential medicines access survey in public hospitals of Burkina Faso
    Saouadogo, H.
    Compaore, M.
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 4 (06): : 373 - 380